
---
categories: ["Publications"]
people: ["Joe Zhang", "Heather Mattie", "Haris Shuaib", "Tamishta Hensman", "James T Teo", "Leo Anthony Celi"]
title: Addressing the "elephant in the room" of AI clinical decision support through organisation-level regulation
linktitle: AI clinical decision support
date: 2022-09-15
description: >
 Regulating organisations is outside the traditional regulatory scope of the US FDA, the European Medicines Agency, or the UK Medicines and Healthcare products Regulatory Agency. Whether through expansion of reach, or delegation to seprate (or new) agencies, organisational-level regulation may be the only feasible approach to ensuring quality ans safety in the increasing number of AI CDS in EHRs.
---

<a href="https://journals.plos.org/digitalhealth/article?id=10.1371/journal.pdig.0000111" target="_blank">PLOS Digital Health</a>

>The elephant then, sitting next to the FDA, is the different considerationg given to algorithmic devices for market, and proprietary algorithms developed within existing EHR (traditionally outside of FDA scope)

